Suzhou Zelgen Biopharmaceuticals (SHA:688266) has an average rating of buy and mean price target of 154.25 yuan, according to analysts polled by FactSet.
What else is happening in Research?
Research
Truist Securities Downgrades Sila Realty Trust to Hold From Buy, Raises Price Target to $30 From $28
Truist Securities Downgrades Sila Realty Trust to Hold From Buy, Raises Price Target to $30 From $28
$SILA
Research
Leerink Downgrades Bio-Techne to Market Perform From Outperform, Price Target is $73
Bio-Techne (TECH) has an average rating of overweight and mean price target of $65.33, according to analysts polled by FactSet.Price: $70.50, Change: $+11.62, Percent Change: +19.74%
$TECH
Research
Evercore ISI Upgrades Bio-Techne to Outperform From In Line, Adjusts Price Target to $73 From $50
Bio-Techne (TECH) has an average rating of overweight and mean price target of $65.33, according to analysts polled by FactSet.
$TECH